Method of chinese herbal medicine extract used for treating multiple diseases caused by drug resistant bacteria infection
AssigneeSun Yat-Sen University
InventorsWeiwei Su, Chong Liu, Qian Zhou, Peibo Li, Wei Peng, Yonggang Wang
Life of this patent
Estimating the term…
Abstract
Disclosed is a new drug application of a Pithecellobium clypearia Benth Extract (EA), and particularly is a method of the EA used for treating multiple diseases caused by drug resistant bacteria infection. Related drug resistant bacteria include a Multi-Drug Resistant (MDR) Acinetobacter baumannii (MDRAB), an MDR Pseudomonas aeruginosa (MDRPA), an Extended-Spectrum Beta-Lactamase (ESBL) producing Escherichia coli (ECO) and an ESBL-producing Klebsiella pneumonia (KPN).
Claims3
A method of treating a disease caused by an Extended-Spectrum Beta-Lactamase producing Escherichia coli infection, comprising administering a Pithecellobium clypearia Benth Extract (EA) in combination with at least one antibiotic selected from the group consisting of Amikacin and Sulfamethoxazole, wherein the EA is a water extract or ethanol extract.
Dependencies are inferred from the claim text.